XIX LipidClub and Therapeutic Apheresis Pictures
Author Archives: Mighty Medic
19th LIPID CLUB AND THERAPEUTIC APHERESIS 2024 Edition
MIGHTY MEDIC Org.’s Advanced Clinical Major Seminary and Educational Forum on Clinical Lipidology, Metabolic Disorders, Extracorporeal Therapeutic Techniques, and Atherosclerosis Prevention Seminario Clinico Avanzato e formazione continua in Lipidologia Clinica, Disturbi del Metabolismo, Tecniche Terapeutiche Extracorporee e Prevenzione dell’Aterosclerosi Peschiera del Garda, Italy, April 18-19, 2024 FINAL PROGRAM
EVKEEZA (EVINACUMAB) AVAILABLE IN ITALY
There is a new reality in Italy that is likely to affect all of Europe, as was the case with Lomitapide. “Evinacumab is reimbursed as an adjunct to diet and other therapies aimed at reducing low-density lipoprotein cholesterol (LDL-C) for the treatment of adult and adolescent patients aged 12 years …
1st ILEP VIRTUAL SYMPOSIUM on CARDIOVASCULAR PREVENTION
1st ILEP (International Lipid Expert Panel) virtual symposium on cardiovascular prevention will be held on March 19th, 2022. Symposium Chairman: Prof. Maciej Banach Visit ILEP web site at: https://ilep.eu/ Program
16th LIPIDCLUB AND THERAPEUTIC APHERESIS
PICTURES OF THE EVENT October 7-8, 2021 – Verona 16th LIPID CLUB AND THERAPEUTIC APHERESIS Seminary and Educational Forum on Clinical Lipidology, Metabolic Disorders, Extracorporeal Therapeutic Techniques, and Atherosclerosis Prevention Verona, October 7-8, 2021Camera di Commercio, Industria Artigianato e Aricoltura di Verona Corso Porta Nuova, 96 – 37122 Verona VR …
FCS Announcement
We are collecting anonymised information on patients with familial chylomicronaemia syndrome (FCS)/multifactorial chylomicronaemia syndrome (MCS) as a service evaluation & quality improvement project. The project aims to improve understanding of natural history of FCS and to validate the use of FCS scoring algorithm. The project is approved by Manchester University …